|
|
||||||||
1 Department of Pathology, University of Washington, Seattle, Washington;
2 Laboratory of Neurobiology and Neuroregenerative Medicine-"Carlo Besta" Institute, Milan, Italy; and
3 Division of Pathology and Laboratory Medicine, Veterans Administration Puget Sound Health Care System, Seattle, Washington
The purpose of this study was to identify novel transcriptional events occurring in the aortic wall before angiogenesis. We used a defined tissue culture system that takes advantage of the capacity of rat aortic rings to generate neovessels ex vivo in response to angiogenic factor stimulation. Total RNA isolated from aortic rings 18 h posttreatment with angiopoietin (Ang)-1 or vascular endothelial growth factor (VEGF) was used to probe oligonucleotide microarrays. Many genes were up- or downregulated by either Ang-1 or VEGF, with a subset being affected by treatment with both growth factors. Grouping of genes by biological function revealed that Ang-1 and VEGF both upregulated a host of immune-related genes including many inflammatory cytokines. A mixture of the Ang-1- and VEGF-induced cytokines stimulated the spontaneous angiogenic response of aortic rings and was synergistic with a low dose of recombinant VEGF. This effect was associated with enhanced recruitment of adventitial macrophages and dendritic cells in the angiogenic outgrowths. Thus Ang-1 and VEGF activate the innate immune system of the vessel wall, stimulating the production of proangiogenic inflammatory cytokines before the emergence of neovessels. This hitherto unreported feature of the angiogenic response might represent an important early component of the cellular and molecular cascade responsible for the angiogenic response of the aortic wall.
aorta; oligonucleotide microarray; gene profiling
This article has been cited by other articles:
![]() |
N. Figueroa-Vega, P. Sanz-Cameno, R. Moreno-Otero, F. Sanchez-Madrid, R. Gonzalez-Amaro, and M. Marazuela Serum Levels of Angiogenic Molecules in Autoimmune Thyroid Diseases and Their Correlation with Laboratory and Clinical Features J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1145 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
Errata J. Leukoc. Biol., December 1, 2008; 84(6): 1623a - 1623. [Full Text] [PDF] |
||||
![]() |
J.-X. Chen and A. Stinnett Ang-1 Gene Therapy Inhibits Hypoxia-Inducible Factor-1{alpha} (HIF-1{alpha})-Prolyl-4-Hydroxylase-2, Stabilizes HIF-1{alpha} Expression, and Normalizes Immature Vasculature in db/db Mice Diabetes, December 1, 2008; 57(12): 3335 - 3343. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gelati, A. C. Aplin, E. Fogel, K. D. Smith, and R. F. Nicosia The Angiogenic Response of the Aorta to Injury and Inflammatory Cytokines Requires Macrophages J. Immunol., October 15, 2008; 181(8): 5711 - 5719. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Voskas, Y. Babichev, L. S. Ling, J. Alami, Y. Shaked, R. S. Kerbel, B. Ciruna, and D. J. Dumont An eosinophil immune response characterizes the inflammatory skin disease observed in Tie-2 transgenic mice J. Leukoc. Biol., July 1, 2008; 84(1): 59 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Khorram, N. Khorram, M. Momeni, G. Han, J. Halem, M. Desai, and M. G. Ross Maternal undernutrition inhibits angiogenesis in the offspring: a potential mechanism of programmed hypertension Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R745 - R753. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |